 |
PDBsum entry 1mir
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.22.1
- cathepsin B.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Hydrolysis of proteins with broad specificity for peptide bonds. Preferentially cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates (thus differing from cathepsin L). In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Structure
4:405-416
(1996)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion.
|
|
M.Cygler,
J.Sivaraman,
P.Grochulski,
R.Coulombe,
A.C.Storer,
J.S.Mort.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
BACKGROUND: Cysteine proteases of the papain superfamily are synthesized as
inactive precursors with a 60-110 residue N-terminal prosegment. The propeptides
are potent inhibitors of their parent proteases. Although the proregion binding
mode has been elucidated for all other protease classes, that of the cysteine
proteases remained elusive. RESULTS: We report the three-dimensional structure
of rat procathepsin B, determined at 2.8 A resolution. The 62-residue proregion
does not form a globular structure on its own, but folds along the surface of
mature cathepsin B. The N-terminal part of the proregion packs against a surface
loop, with Trp24p (p indicating the proregion) playing a pivotal role in these
interactions. Inhibition occurs by blocking access to the active site: part of
the proregion enters the substrate-binding cleft in a similar manner to a
natural substrate, but in a reverse orientation. CONCLUSIONS: The structure of
procathepsin B provides the first insight into the mode of interaction between a
mature cysteine protease from the papain superfamily and its prosegment.
Maturation results in only one loop of cathepsin B changing conformation
significantly, replacing contacts lost by removal of the prosegment. Contrary to
many other proproteases, no rearrangement of the N terminus occurs following
activation. Binding of the prosegment involves interaction with regions of the
enzyme remote from the substrate-binding cleft and suggests a novel strategy for
inhibitor design. The region of the prosegment where the activating cleavage
occurs makes little contact with the enzyme, leading to speculation on the
activation mechanism.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Molecular surface of the mature portion of
procathepsin B with the prosegment shown as a worm
representation. The view is toward the active site. Figure 2.
Molecular surface of the mature portion of procathepsin B with
the prosegment shown as a worm representation. The view is
toward the active site. (The figure was prepared using GRASP
[[3]48].)
|
 |
Figure 5.
Figure 5. Contacts between the prosegment and catB within the
occluding-loop crevice. Hydrogen bonds are shown as dashed
lines. The prosegment is drawn in dark lines. Figure 5.
Contacts between the prosegment and catB within the
occluding-loop crevice. Hydrogen bonds are shown as dashed
lines. The prosegment is drawn in dark lines. (Figure was
created using MOLSCRIPT [[3]47].)
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Cell Press:
Structure
(1996,
4,
405-416)
copyright 1996.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
X.Yao,
J.Zhang,
J.Sun,
and
B.Liu
(2011).
Recombinant expression, characterization and expressional analysis of clam Meretrix meretrix cathepsin B, an enzyme involved in nutrient digestion.
|
| |
Mol Biol Rep,
38,
1861-1868.
|
 |
|
|
|
|
 |
M.Renko,
U.Požgan,
D.Majera,
and
D.Turk
(2010).
Stefin A displaces the occluding loop of cathepsin B only by as much as required to bind to the active site cleft.
|
| |
FEBS J,
277,
4338-4345.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Serbielle,
S.Moreau,
F.Veillard,
E.Voldoire,
A.Bézier,
M.A.Mannucci,
A.N.Volkoff,
J.M.Drezen,
G.Lalmanach,
and
E.Huguet
(2009).
Identification of parasite-responsive cysteine proteases in Manduca sexta.
|
| |
Biol Chem,
390,
493-502.
|
 |
|
|
|
|
 |
J.R.Pungercar,
D.Caglic,
M.Sajid,
M.Dolinar,
O.Vasiljeva,
U.Pozgan,
D.Turk,
M.Bogyo,
V.Turk,
and
B.Turk
(2009).
Autocatalytic processing of procathepsin B is triggered by proenzyme activity.
|
| |
FEBS J,
276,
660-668.
|
 |
|
|
|
|
 |
K.C.Pandey,
D.T.Barkan,
A.Sali,
and
P.J.Rosenthal
(2009).
Regulatory elements within the prodomain of falcipain-2, a cysteine protease of the malaria parasite Plasmodium falciparum.
|
| |
PLoS One,
4,
e5694.
|
 |
|
|
|
|
 |
I.Redzynia,
A.Ljunggren,
M.Abrahamson,
J.S.Mort,
J.C.Krupa,
M.Jaskolski,
and
G.Bujacz
(2008).
Displacement of the occluding loop by the parasite protein, chagasin, results in efficient inhibition of human cathepsin B.
|
| |
J Biol Chem,
283,
22815-22825.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.Mallorquí-Fernández,
S.P.Manandhar,
G.Mallorquí-Fernández,
I.Usón,
K.Wawrzonek,
T.Kantyka,
M.Solà,
I.B.Thøgersen,
J.J.Enghild,
J.Potempa,
and
F.X.Gomis-Rüth
(2008).
A New Autocatalytic Activation Mechanism for Cysteine Proteases Revealed by Prevotella intermedia Interpain A.
|
| |
J Biol Chem,
283,
2871-2882.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Caglic,
J.R.Pungercar,
G.Pejler,
V.Turk,
and
B.Turk
(2007).
Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions.
|
| |
J Biol Chem,
282,
33076-33085.
|
 |
|
|
|
|
 |
E.Wieczerzak,
S.Rodziewicz-Motowidło,
E.Jankowska,
A.Giełdoń,
and
J.Ciarkowski
(2007).
An enormously active and selective azapeptide inhibitor of cathepsin B.
|
| |
J Pept Sci,
13,
536-543.
|
 |
|
|
|
|
 |
E.Wieczerzak,
E.Jankowska,
S.Rodziewicz-Motowidło,
A.Giełdoń,
J.Lagiewka,
Z.Grzonka,
M.Abrahamson,
A.Grubb,
and
D.Brömme
(2005).
Novel azapeptide inhibitors of cathepsins B and K. Structural background to increased specificity for cathepsin B.
|
| |
J Pept Res,
66,
1.
|
 |
|
|
|
|
 |
M.Horn,
L.Dolecková-Maresová,
L.Rulísek,
M.Mása,
O.Vasiljeva,
B.Turk,
T.Gan-Erdene,
M.Baudys,
and
M.Mares
(2005).
Activation processing of cathepsin H impairs recognition by its propeptide.
|
| |
Biol Chem,
386,
941-947.
|
 |
|
|
|
|
 |
A.Rossi,
Q.Deveraux,
B.Turk,
and
A.Sali
(2004).
Comprehensive search for cysteine cathepsins in the human genome.
|
| |
Biol Chem,
385,
363-372.
|
 |
|
|
|
|
 |
D.H.Ebert,
S.A.Kopecky-Bromberg,
and
T.S.Dermody
(2004).
Cathepsin B Is Inhibited in Mutant Cells Selected during Persistent Reovirus Infection.
|
| |
J Biol Chem,
279,
3837-3851.
|
 |
|
|
|
|
 |
A.N.Hodder,
D.R.Drew,
V.C.Epa,
M.Delorenzi,
R.Bourgon,
S.K.Miller,
R.L.Moritz,
D.F.Frecklington,
R.J.Simpson,
T.P.Speed,
R.N.Pike,
and
B.S.Crabb
(2003).
Enzymic, phylogenetic, and structural characterization of the unusual papain-like protease domain of Plasmodium falciparum SERA5.
|
| |
J Biol Chem,
278,
48169-48177.
|
 |
|
|
|
|
 |
D.N.Li,
S.P.Matthews,
A.N.Antoniou,
D.Mazzeo,
and
C.Watts
(2003).
Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo.
|
| |
J Biol Chem,
278,
38980-38990.
|
 |
|
|
|
|
 |
D.Turk,
and
G.Guncar
(2003).
Lysosomal cysteine proteases (cathepsins): promising drug targets.
|
| |
Acta Crystallogr D Biol Crystallogr,
59,
203-213.
|
 |
|
|
|
|
 |
R.Filipek,
M.Rzychon,
A.Oleksy,
M.Gruca,
A.Dubin,
J.Potempa,
and
M.Bochtler
(2003).
The Staphostatin-staphopain complex: a forward binding inhibitor in complex with its target cysteine protease.
|
| |
J Biol Chem,
278,
40959-40966.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.Lalmanach,
A.Boulangé,
C.Serveau,
F.Lecaille,
J.Scharfstein,
F.Gauthier,
and
E.Authié
(2002).
Congopain from Trypanosoma congolense: drug target and vaccine candidate.
|
| |
Biol Chem,
383,
739-749.
|
 |
|
|
|
|
 |
M.Horn,
M.Baudys,
Z.Voburka,
I.Kluh,
J.Vondrásek,
and
M.Mares
(2002).
Free-thiol Cys331 exposed during activation process is critical for native tetramer structure of cathepsin C (dipeptidyl peptidase I).
|
| |
Protein Sci,
11,
933-943.
|
 |
|
|
|
|
 |
C.Therrien,
P.Lachance,
T.Sulea,
E.O.Purisima,
H.Qi,
E.Ziomek,
A.Alvarez-Hernandez,
W.R.Roush,
and
R.Ménard
(2001).
Cathepsins X and B can be differentiated through their respective mono- and dipeptidyl carboxypeptidase activities.
|
| |
Biochemistry,
40,
2702-2711.
|
 |
|
|
|
|
 |
D.Turk,
V.Janjić,
I.Stern,
M.Podobnik,
D.Lamba,
S.W.Dahl,
C.Lauritzen,
J.Pedersen,
V.Turk,
and
B.Turk
(2001).
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases.
|
| |
EMBO J,
20,
6570-6582.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
F.Lecaille,
E.Authié,
T.Moreau,
C.Serveau,
F.Gauthier,
and
G.Lalmanach
(2001).
Subsite specificity of trypanosomal cathepsin L-like cysteine proteases. Probing the S2 pocket with phenylalanine-derived amino acids.
|
| |
Eur J Biochem,
268,
2733-2741.
|
 |
|
|
|
|
 |
R.Ménard,
C.Therrien,
P.Lachance,
T.Sulea,
H.Qo,
A.D.Alvarez-Hernandez,
and
W.R.Roush
(2001).
Cathepsins X and B display distinct activity profiles that can be exploited for inhibitor design.
|
| |
Biol Chem,
382,
839-845.
|
 |
|
|
|
|
 |
V.Turk,
B.Turk,
and
D.Turk
(2001).
Lysosomal cysteine proteases: facts and opportunities.
|
| |
EMBO J,
20,
4629-4633.
|
 |
|
|
|
|
 |
D.Greenbaum,
K.F.Medzihradszky,
A.Burlingame,
and
M.Bogyo
(2000).
Epoxide electrophiles as activity-dependent cysteine protease profiling and discovery tools.
|
| |
Chem Biol,
7,
569-581.
|
 |
|
|
|
|
 |
R.I.Brinkworth,
J.F.Tort,
P.J.Brindley,
and
J.P.Dalton
(2000).
Phylogenetic relationships and theoretical model of human cathepsin W (lymphopain), a cysteine proteinase from cytotoxic T lymphocytes.
|
| |
Int J Biochem Cell Biol,
32,
373-384.
|
 |
|
|
|
|
 |
T.F.Kagawa,
J.C.Cooney,
H.M.Baker,
S.McSweeney,
M.Liu,
S.Gubba,
J.M.Musser,
and
E.N.Baker
(2000).
Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease.
|
| |
Proc Natl Acad Sci U S A,
97,
2235-2240.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.Turk,
I.Dolenc,
B.Lenarcic,
I.Krizaj,
V.Turk,
J.G.Bieth,
and
I.Björk
(1999).
Acidic pH as a physiological regulator of human cathepsin L activity.
|
| |
Eur J Biochem,
259,
926-932.
|
 |
|
|
|
|
 |
C.Czaplewski,
Z.Grzonka,
M.Jaskólski,
F.Kasprzykowski,
M.Kozak,
E.Politowska,
and
J.Ciarkowski
(1999).
Binding modes of a new epoxysuccinyl-peptide inhibitor of cysteine proteases. Where and how do cysteine proteases express their selectivity?
|
| |
Biochim Biophys Acta,
1431,
290-305.
|
 |
|
|
|
|
 |
C.M.Hosfield,
J.S.Elce,
P.L.Davies,
and
Z.Jia
(1999).
Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation.
|
| |
EMBO J,
18,
6880-6889.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Krepela,
J.Procházka,
and
B.Kárová
(1999).
Regulation of cathepsin B activity by cysteine and related thiols.
|
| |
Biol Chem,
380,
541-551.
|
 |
|
|
|
|
 |
G.Guncar,
G.Pungercic,
I.Klemencic,
V.Turk,
and
D.Turk
(1999).
Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
|
| |
EMBO J,
18,
793-803.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.M.LaLonde,
B.Zhao,
C.A.Janson,
K.J.D'Alessio,
M.S.McQueney,
M.J.Orsini,
C.M.Debouck,
and
W.W.Smith
(1999).
The crystal structure of human procathepsin K.
|
| |
Biochemistry,
38,
862-869.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Sivaraman,
M.Lalumière,
R.Ménard,
and
M.Cygler
(1999).
Crystal structure of wild-type human procathepsin K.
|
| |
Protein Sci,
8,
283-290.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.E.Lukong,
M.A.Elsliger,
J.S.Mort,
M.Potier,
and
A.V.Pshezhetsky
(1999).
Identification of UDP-N-acetylglucosamine-phosphotransferase-binding sites on the lysosomal proteases, cathepsins A, B, and D.
|
| |
Biochemistry,
38,
73-80.
|
 |
|
|
|
|
 |
M.E.McGrath
(1999).
The lysosomal cysteine proteases.
|
| |
Annu Rev Biophys Biomol Struct,
28,
181-204.
|
 |
|
|
|
|
 |
T.Okamoto,
A.Yuki,
N.Mitsuhashi,
T.Minamikawa,
and
T.Mimamikawa
(1999).
Asparaginyl endopeptidase (VmPE-1) and autocatalytic processing synergistically activate the vacuolar cysteine proteinase (SH-EP).
|
| |
Eur J Biochem,
264,
223-232.
|
 |
|
|
|
|
 |
Y.V.Matsuka,
S.Pillai,
S.Gubba,
J.M.Musser,
and
S.B.Olmsted
(1999).
Fibrinogen cleavage by the Streptococcus pyogenes extracellular cysteine protease and generation of antibodies that inhibit enzyme proteolytic activity.
|
| |
Infect Immun,
67,
4326-4333.
|
 |
|
|
|
|
 |
A.A.Sinha,
B.J.Quast,
M.J.Wilson,
P.K.Reddy,
D.F.Gleason,
and
B.F.Sloane
(1998).
Codistribution of procathepsin B and mature cathepsin B forms in human prostate tumors detected by confocal and immunofluorescence microscopy.
|
| |
Anat Rec,
252,
281-289.
|
 |
|
|
|
|
 |
A.R.Khan,
and
M.N.James
(1998).
Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.
|
| |
Protein Sci,
7,
815-836.
|
 |
|
|
|
|
 |
D.Turk,
G.Guncar,
M.Podobnik,
and
B.Turk
(1998).
Revised definition of substrate binding sites of papain-like cysteine proteases.
|
| |
Biol Chem,
379,
137-147.
|
 |
|
|
|
|
 |
M.E.McGrath,
J.T.Palmer,
D.Brömme,
and
J.R.Somoza
(1998).
Crystal structure of human cathepsin S.
|
| |
Protein Sci,
7,
1294-1302.
|
 |
|
|
|
|
 |
M.T.Stubbs,
M.Renatus,
and
W.Bode
(1998).
An active zymogen: unravelling the mystery of tissue-type plasminogen activator.
|
| |
Biol Chem,
379,
95.
|
 |
|
|
|
|
 |
A.R.Khan,
M.M.Cherney,
N.I.Tarasova,
and
M.N.James
(1997).
Structural characterization of activation 'intermediate 2' on the pathway to human gastricsin.
|
| |
Nat Struct Biol,
4,
1010-1015.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.L.Sohl,
A.K.Shiau,
S.D.Rader,
B.J.Wilk,
and
D.A.Agard
(1997).
Inhibition of alpha-lytic protease by pro region C-terminal steric occlusion of the active site.
|
| |
Biochemistry,
36,
3894-3902.
|
 |
|
|
|
|
 |
M.E.McGrath,
J.L.Klaus,
M.G.Barnes,
and
D.Brömme
(1997).
Crystal structure of human cathepsin K complexed with a potent inhibitor.
|
| |
Nat Struct Biol,
4,
105-109.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.A.Gillmor,
C.S.Craik,
and
R.J.Fletterick
(1997).
Structural determinants of specificity in the cysteine protease cruzain.
|
| |
Protein Sci,
6,
1603-1611.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.C.Johnston,
C.N.Larsen,
W.J.Cook,
K.D.Wilkinson,
and
C.P.Hill
(1997).
Crystal structure of a deubiquitinating enzyme (human UCH-L3) at 1.8 A resolution.
|
| |
EMBO J,
16,
3787-3796.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
W.Baumeister,
Z.Cejka,
M.Kania,
and
E.Seemüller
(1997).
The proteasome: a macromolecular assembly designed to confine proteolysis to a nanocompartment.
|
| |
Biol Chem,
378,
121-130.
|
 |
|
|
|
|
 |
D.Maes,
J.Bouckaert,
F.Poortmans,
L.Wyns,
and
Y.Looze
(1996).
Structure of chymopapain at 1.7 A resolution.
|
| |
Biochemistry,
35,
16292-16298.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
R.Coulombe,
P.Grochulski,
J.Sivaraman,
R.Ménard,
J.S.Mort,
and
M.Cygler
(1996).
Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.
|
| |
EMBO J,
15,
5492-5503.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |